Status:
COMPLETED
The Effect of Intracameral Carbachol and Epinephrine on Choroidal Thickness
Lead Sponsor:
Ordu University
Conditions:
Epinephrine Toxicity
Cataract
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
81 eyes of 81 patients undergoing cataract surgery were included in this prospective interventional study. During cataract surgery, intracameral carbachol was applied to 27 eyes, intracameral epinephr...
Detailed Description
This study consisted of three groups: epinephrine group, carbachol group, and control group. Intracameral carbachol and epinephrine was not used for complication management. In the epinephrine group, ...
Eligibility Criteria
Inclusion
- over 18 years old
- patients with cataracts
Exclusion
- hypertension and diabetes
- ocular problems such as uveitis, glaucoma, amblyopia
- maculopathy, retinal dystrophy
- any previous ocular surgery
- eye trauma
- congenital cataracts
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT05225597
Start Date
January 1 2021
End Date
December 30 2021
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ordu University
Ordu, ABD Dışında, Turkey (Türkiye), 52200